Advanced search
Publication Cover
Cell Cycle Volume 20, 2021 - Issue 23
Submit an article Journal homepage
1,066
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling

Jian-Qing Chena Department of Digestive Internal, Yangpu Shidong Hospital, Anhui Medical University, Shanghai, ChinaView further author information
,
Yuan-Ping Taob National Liver Tissue Bank, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, ChinaView further author information
,
Yong-Gang Hongc Department of Colorectal Surgery, Changhai Hospital, Second Military Medical University, Shanghai, P.R. ChinaView further author information
,
Hui-Fen Lid Department of intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, ChinaView further author information
,
Zhi-Ping Huange Department of Hepatobiliary Surgery, General Hospital of Southern Theatre Command, Guangzhou, ChinaView further author information
,
Xuan-Fu Xua Department of Digestive Internal, Yangpu Shidong Hospital, Anhui Medical University, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Liang-Kai Hua Department of Digestive Internal, Yangpu Shidong Hospital, Anhui Medical University, Shanghai, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 2507-2518 | Received 03 May 2021, Accepted 31 May 2021, Published online: 17 Oct 2021

References

  • Chen JQ, Tao YP, Hong YG, Li HF, Huang ZP, Xu XF, Zheng H, Hu LK. M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling. Cell Cycle. 2021 Dec;20(23):2507–2518.
  • Lin QJ, Yang F, Jin C, et al. Current status and progress of pancreatic cancer in China. World J Gastroenterol. 2015;21:7988–8003.
  • Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
  • Heestand GM, Kurzrock R. Molecular landscape of pancreatic cancer: implications for current clinical trials. Oncotarget. 2015;6:4553–4561.
  • Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318–348.
  • Oldfield LE, Connor AA, Gallinger S. Molecular events in the natural history of pancreatic cancer. Trends Cancer. 2017;3:336–346.
  • Cicenas J, Kvederaviciute K, Meskinyte I, et al. Cicenas J. KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer. Cancers (Basel). 2017;9:42.
  • Ma Z, and Ji J. N6-methyladenosine (m6A) RNA modification in cancer stem cells. Stem Cells. 2020 Sep 27.
  • Gan H, Hong L, Yang F, et al. Progress in epigenetic modification of mRNA and the function of m6A modification. Sheng Wu Gong Cheng Xue Bao. 2019;35:775–783.
  • Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.
  • Xia T, Wu X, Cao M, et al. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. Pathol Res Pract. 2019;215:152666.
  • Chi Y, Wang J, Wang J, et al. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8:1015.
  • Lv Y, Huang S. Role of non-coding RNA in pancreatic cancer. Oncol Lett. 2019;18:3963–3973.
  • Penna GC, Vaisman F, Vaisman M, et al. Molecular markers involved in tumorigenesis of thyroid carcinoma: focus on aggressive histotypes. Cytogenet Genome Res. 2016;150:194–207.
  • Frey HA, Stout MJ, Pearson LN, et al. Genetic variation associated with preterm birth in African-American women. Am J Obstet Gynecol. 2016;215:235.e1–8.
  • Wang L, Li J, Zhao H, et al. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes. Mol Biosyst. 2016;12:711–720.
  • Liu K, Yao H, Wen Y, et al. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Biochim Biophys Acta Mol Basis Dis. 2018;1864:2871–2880.
  • Chen X, Xu X, Pan B, et al. miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer. Aging (Albany NY). 2018;10:3421–3437.
  • Tang XJ, Wang W, Hann SS. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie. 2019;163:58–72.
  • Xu F, Li H, Hu C. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer. Biosci Rep. 2019;39. DOI:10.1042/BSR20180551
  • Ding H, Cui L, and Wang C. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma. Neurol Res. 2020;43(3): 210–219.
  • Wang HF, Lv JQ, Li HH, et al. High long non-coding LIFR-AS1 expression correlates with poor survival in gastric carcinoma. Eur Rev Med Pharmacol Sci. 2020;24:5378–5384.
  • Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.
  • Yin C, Mou Q, Pan X, et al. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25. Thorac Cancer. 2018;9:472–479.
  • Trinh XB, Tjalma WAA, Vermeulen PB, et al. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. Br J Cancer. 2009;100:971–978.
  • Rodrigues DA, Guerra FS, Sagrillo FS, et al. Design, synthesis, and pharmacological evaluation of first-in-class multitarget N-Acylhydrazone derivatives as selective HDAC6/8 and PI3Kalpha inhibitors. ChemMedChem. 2020;15:539–551.
  • Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10:307–318.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.